Intensive Care Medicine
Patient Safety

Patient Safety in ICU

Patient safety in the intensive care unit (ICU) represents one of the most critical domains of modern critical care practice. ICU patients are among the most vulnerable in healthcare, with physiological instability,...

58 min read

Clinical board

A visual summary of the highest-yield teaching signals on this page.

Urgent signals

Safety-critical features pulled from the topic metadata.

  • CLABSI (central line-associated bloodstream infection) rates greater than 2.7/1000 catheter-days
  • VAP (ventilator-associated pneumonia) greater than 10 cases/1000 ventilator-days
  • High-alert medication errors (insulin, heparin, vasopressors)
  • Pressure injury development despite prevention measures

Exam focus

Current exam surfaces linked to this topic.

  • CICM Fellowship Written
  • CICM Fellowship Viva

Editorial and exam context

CICM Fellowship Written
CICM Fellowship Viva
Clinical reference article

Patient Safety in the Intensive Care Unit

Clinical Overview

Patient safety in the intensive care unit (ICU) represents one of the most critical domains of modern critical care practice. ICU patients are among the most vulnerable in healthcare, with physiological instability, complex comorbidities, and exposure to numerous invasive devices and high-risk medications. The convergence of these factors creates an environment where medical errors and adverse events are disproportionately common compared to other hospital settings.

The Institute of Medicine's landmark report "To Err Is Human" (2000) first brought patient safety to the forefront of healthcare, estimating that up to 98,000 deaths annually in the United States were attributable to preventable medical errors. Subsequent research has demonstrated that ICU patients experience medication errors at rates 1.5-2 times higher than general ward patients, with approximately 1.7 medication errors per patient day in ICU settings.

The complexity of ICU care creates multiple safety vulnerabilities: polypharmacy (10-20 concurrent medications), invasive devices (central venous catheters, endotracheal tubes, urinary catheters), mechanical ventilation, and the need for frequent interventions by multiple healthcare professionals. This complexity, combined with the physiological reserve limitations of critically ill patients, means that small errors can rapidly escalate into catastrophic outcomes.

The WHO's Patient Safety Curriculum Guide emphasises that patient safety is not merely the absence of harm but involves creating systems that prevent errors and minimize harm when errors occur. This framework, combined with evidence-based bundles, checklists, and quality improvement methodologies, forms the foundation of modern ICU safety practice.

Epidemiology of ICU Safety Events

Incidence and Impact

Answer: Key Statistics on ICU Safety Events

  • Medication errors: 1.7 errors per patient day; 78% of serious medical errors in ICU are medication-related
  • CLABSI: Baseline rate 2.7 infections per 1000 catheter-days (can be reduced to 0 with bundle implementation)
  • VAP: Incidence 10-20 cases per 1000 ventilator-days; associated with 13% attributable mortality
  • Pressure injuries: ICU incidence 10-40%; Stage III/IV injuries associated with 60% mortality
  • ICU falls: 2-9 falls per 1000 patient-days; 25-30% result in injury
  • Alarm burden: 72-99% of ICU alarms are non-actionable; only 8% require immediate intervention

Risk Factors for ICU Safety Events

Patient-related factors:

  • Age greater than 65 years (comorbidities, reduced physiological reserve)
  • Severity of illness (APACHE II score greater than 20, SOFA score greater than 8)
  • Impaired consciousness or delirium
  • Immobility and prolonged ICU stay
  • Multisystem organ failure
  • Immunocompromise

System-related factors:

  • Nurse-to-patient ratio greater than 1:2
  • Inexperienced staff or high turnover
  • Communication failures during handoffs
  • Inadequate monitoring or alarm systems
  • Lack of standardised protocols
  • Equipment malfunction or inappropriate use
  • Interruptions during critical tasks

Procedure-related factors:

  • Emergency versus elective procedures
  • Invasive device use (CVC, ETT, urinary catheter)
  • Prolonged device duration
  • Non-optimal device placement
  • Inadequate aseptic technique

Medication Safety

High-Alert Medications in ICU

High-alert medications are drugs that bear a heightened risk of causing significant patient harm when used in error. In the ICU, these medications are frequently administered via continuous intravenous infusion, requiring precise titration and monitoring.

Key Point: ISMP High-Alert Medications in ICU

  1. Vasoactive agents - epinephrine, norepinephrine, dopamine, vasopressin, phenylephrine
  2. Anticoagulants - unfractionated heparin, low-molecular-weight heparin, direct oral anticoagulants
  3. Sedatives and analgesics - propofol, dexmedetomidine, fentanyl, midazolam
  4. Insulin - intravenous infusions for glycemic control
  5. Neuromuscular blocking agents - rocuronium, vecuronium, succinylcholine, cisatracurium
  6. Concentrated electrolytes - potassium chloride, magnesium sulfate, sodium chloride (greater than 0.9%)
  7. Opioids - morphine, hydromorphone, methadone, oxycodone
  8. Antiarrhythmics - amiodarone, lidocaine, adenosine
  9. Chemotherapeutic agents - when used in ICU settings

Medication Error Categories

Prescribing errors:

  • Wrong drug, dose, frequency, or route
  • Allergy or contraindication not considered
  • Drug-drug interactions overlooked
  • Incorrect weight-based calculations
  • Failure to adjust for renal or hepatic dysfunction

Dispensing errors:

  • Wrong drug or concentration dispensed
  • Incorrect labelling or storage
  • Preparation errors (wrong diluent, concentration)
  • Look-alike/sound-alike confusion

Administration errors:

  • Wrong patient, drug, dose, route, time (Five Rights violations)
  • Incorrect infusion pump programming
  • Inadequate monitoring during administration
  • Bypassing safety mechanisms (smart pumps)

Monitoring errors:

  • Failure to monitor therapeutic effects
  • Missed adverse drug reactions
  • Inadequate therapeutic drug monitoring
  • Failure to adjust for changing physiology

Strategies for Medication Safety

Technology solutions:

TechnologyMechanismEvidence of Benefit
Computerised Physician Order Entry (CPOE)Standardises prescribing, dose calculations, drug interaction alertsReduces prescribing errors by 55-83% (PMID 12673395)
Clinical Decision Support Systems (CDSS)Real-time alerts for contraindications, interactions, dose adjustmentsPrevents 4-14% of potential ADEs (PMID 15145412)
Smart Infusion Pumps with DERSLimits maximum infusion rates, prevents programming errorsReduces programming errors by 73% (PMID 16551853)
Barcode Medication Administration (BCMA)Ensures Five Rights via barcode scanning at bedsideReduces administration errors by 41-86% (PMID 16042336)
Automated Dispensing CabinetsControls access to high-alert medications, tracks usageReduces dispensing errors and diversion risk

Standardisation strategies:

  1. Standardised concentrations - limit the number of available concentrations for high-alert drips to reduce calculation errors
  2. Pre-mixed infusions - pharmacy-compounded high-alert medications where feasible
  3. Drug libraries - standardised drug libraries in smart pumps with institution-specific limits
  4. Double-check procedures - independent double-checks for high-alert medications (insulin, heparin, chemotherapeutic agents)
  5. Tallman lettering - use of distinctive typography for look-alike drug names (e.g., hydralazine vs hydroxyzine)
  6. Standardised dosing protocols - protocol-driven sedation, analgesia, insulin infusions

Human factors:

  1. Clinical pharmacist involvement - ICU pharmacist participation on daily rounds reduces preventable ADEs by 66% (PMID 15896638)
  2. Medication reconciliation - comprehensive reconciliation at admission, transfer, and discharge
  3. Education and training - regular staff education on high-alert medications and safety procedures
  4. Non-punitive reporting culture - encourage voluntary error reporting for learning
  5. Standardised communication - use of SBAR for medication-related handoffs

Specific medication safety bundles:

Insulin Safety Bundle:

  • Standardised insulin infusion protocols
  • Separate storage of concentrated insulin (100 units/mL) from regular insulin
  • Dedicated IV lines for insulin infusions
  • Point-of-care glucose monitoring every 1-2 hours during infusion
  • Capillary blood glucose documentation in medication administration record
  • "Do not use" abbreviations: "U" for units (write "units")

Anticoagulant Safety Bundle:

  • Separate storage of unfractionated heparin and LMWH
  • Standardised dosing nomograms for UFH with target aPTT range
  • Anti-Xa monitoring for LMWH in renal impairment
  • Standardised reversal protocols
  • Dedicated bleeding risk assessment scales
  • Time-out procedures before anticoagulant administration

Neuromuscular Blocker Safety Bundle:

  • Mandatory sedation before NMB administration (documented)
  • Train-of-four monitoring during continuous infusions
  • Standardised weaning protocols
  • Eye protection and positioning protocols
  • Ventilator alarm settings adjusted for muscle paralysis
  • Documentation of paralysis indication and duration
Evidence

Evidence: Medication Safety Interventions

  1. Valentin et al. multinational study (PMID 19419179) found that 78% of serious medical errors in ICU were medication-related, with most occurring during the prescribing stage.

  2. Leape et al. (PMID 7474243) demonstrated that computerised physician order entry reduced serious medication errors by 55% and preventable adverse drug events by 17%.

  3. Kane-Gill et al. (PMID 15896638) showed that clinical pharmacist participation on ICU rounds reduced preventable adverse drug events by 66% and the cost of drug therapy by $270,000 per year.

  4. Rothschild et al. (PMID 15942315) found that smart infusion pumps with dose error reduction systems reduced high-risk programming errors by 73% without compromising clinical efficacy.

  5. The Institute for Safe Medication Practices (ISMP) maintains a comprehensive list of high-alert medications that forms the basis for institutional safety priorities.

Central Line-Associated Bloodstream Infection (CLABSI) Prevention

Definition and Impact

CLABSI is a primary bloodstream infection in a patient with a central line that was not present or incubating at the time of catheter insertion. CLABSI is associated with:

  • Increased hospital length of stay (7-21 days)
  • Increased ICU length of stay (5-10 days)
  • Increased mortality (12-25% attributable mortality)
  • Increased hospital costs ($11,000-$36,000 per episode)
  • Significant morbidity including septic shock, metastatic infection

⚠️ Red Flag: CLABSI Rates: A Call to Action

  • Baseline pre-intervention rate: 2.7 infections per 1000 catheter-days
  • Post-bundle implementation target: below 1 infection per 1000 catheter-days
  • Achievable goal: 0 infections with comprehensive bundle implementation (Pronovost 2006, PMID 17192537)

Pathophysiology and Risk Factors

Routes of infection:

  1. Extraluminal contamination - skin organisms migrate along external catheter surface (dominant early infection, below 7 days)
  2. Intraluminal contamination - organisms enter via catheter hub during manipulation (dominant late infection, greater than 7 days)
  3. Haematogenous seeding - distant infection source seeds catheter

Risk factors:

  • Insertion site: femoral > subclavian > internal jugular (highest infection risk for femoral)
  • Emergency insertion
  • Prolonged catheter duration (greater than 7 days)
  • Frequent catheter manipulation (blood draws, medication administration)
  • Inadequate aseptic technique during insertion or maintenance
  • Multi-lumen catheters
  • Patient factors: immunosuppression, neutropenia, diabetes, malnutrition
  • Concomitant infections

CLABSI Prevention Bundle

The Keystone ICU Project (Pronovost et al., 2006) demonstrated that implementation of an evidence-based bundle could reduce CLABSI rates from 2.7 to 0 infections per 1000 catheter-days within 3 months, with sustained reduction over 18 months.

Answer: CLABSI Prevention Bundle (5 Components)

  1. Hand hygiene - wash hands with soap and water or alcohol-based hand rub before and after palpating catheter insertion sites, as well as before and after inserting, replacing, accessing, repairing, or dressing a CVC

  2. Maximal sterile barrier precautions - wear a sterile gown, sterile gloves, mask, and large sterile drape (full body draping) during CVC insertion. Mask should be worn by all personnel in the room during insertion.

  3. Chlorhexidine skin antisepsis - use greater than 0.5% chlorhexidine with alcohol for skin antisepsis before CVC insertion and dressing changes. Allow to dry completely (minimum 30 seconds, ideally 2 minutes) before proceeding.

  4. Optimal catheter site selection - avoid the femoral vein for CVC insertion in adult patients; subclavian vein is associated with lowest infection rates (but higher pneumothorax risk); internal jugular is acceptable alternative

  5. Daily review of line necessity - assess daily whether each CVC remains indicated and remove any non-essential lines promptly

Bundle Components in Detail

Hand Hygiene:

  • Alcohol-based hand rubs (ABHR) are preferred for routine decontamination unless hands are visibly soiled
  • ABHR must contain at least 60% alcohol (ethanol or isopropanol)
  • Soap and water required for Clostridioides difficile or Norovirus outbreaks
  • Technique: 20-30 seconds rubbing all hand surfaces
  • Auditing and feedback essential for compliance (greater than 90% target)

Maximal Sterile Barrier Precautions:

  • Sterile gown fully covers torso and arms
  • Sterile gloves (powder-free recommended)
  • Surgical mask covering nose and mouth
  • Large sterile drape covering patient from head to toe ("full-body drape")
  • All personnel in room must wear mask (not sterile)
  • Create a sterile field and maintain throughout procedure
  • Avoid talking over sterile field

Chlorhexidine Skin Antisepsis:

  • Concentration: 0.5-2% chlorhexidine gluconate with 70% isopropyl alcohol
  • Application: apply in concentric circles from insertion site outward, covering area 5-10 cm in diameter
  • Drying time: minimum 30 seconds, ideally 2 minutes (alcohol component must evaporate)
  • Contraindications: avoid on mucous membranes, near eyes or ears
  • Allergy: chlorhexidine allergy rare but documented (anaphylaxis possible)
  • Alternative: povidone-iodine 10% if chlorhexidine contraindicated (less effective)

Optimal Catheter Site Selection:

  • Subclavian vein: lowest infection rate, but higher pneumothorax risk (1.5-3%)
  • Internal jugular vein: moderate infection risk, lower pneumothorax, higher arterial puncture risk
  • Femoral vein: highest infection rate (2-5× higher than subclavian), risk of DVT, avoid in adults when possible
  • Avoid insertion through burned or infected skin
  • Consider ultrasound guidance for all CVC insertions (reduces complications and attempts)

Daily Review of Line Necessity:

  • Standardised daily checklist for all CVCs
  • Remove CVC if no longer required (e.g., no vasopressors, no TPN, haemodynamically stable)
  • Consider downsizing to smaller gauge or fewer lumens if possible
  • Consider conversion to peripheral lines for intermittent medications
  • Document indication for each CVC and date inserted
  • Prompt removal of unnecessary lines reduces infection risk exponentially

Maintenance Bundle Elements

Beyond the insertion bundle, maintenance practices are critical for CLABSI prevention:

Dressing changes:

  • Transparent semipermeable dressing changed every 7 days or when soiled, loose, or damp
  • Gauze dressing changed every 2 days or when soiled, loose, or damp
  • Chlorhexidine-impregnated sponge dressings (BioPatch) reduce CLABSI risk
  • Use sterile gloves and technique for dressing changes
  • Assess insertion site for redness, tenderness, purulence with each dressing change

Needleless connectors:

  • Change needleless connectors every 96 hours or according to manufacturer guidelines
  • Scrub hub with alcohol for 15 seconds before each access (hub disinfection)
  • Ensure connections are secure to prevent disconnection
  • Use Luer-lock connectors for all CVC connections

Blood sampling:

  • Use dedicated blood culture ports when available
  • Prefer peripheral blood sampling for routine blood draws if possible
  • If CVC must be used, maintain aseptic technique during sampling
  • Flush CVC with normal saline after blood sampling (unless contraindicated)
  • Use closed-loop blood sampling systems where available

Tubing changes:

  • Change administration tubing every 96 hours for continuous infusions
  • Change tubing immediately after blood, lipid, or propofol infusions
  • Replace tubing sets according to manufacturer guidelines
  • Use infusion pump sets with built-in anti-reflux valves

Education and Culture:

  • Regular education on CLABSI prevention for all staff
  • Real-time feedback on CLABSI rates and compliance
  • Empower nurses to stop procedures if sterile technique is breached
  • Non-punitive error reporting culture
  • Celebrate successes (zero infection months)
Evidence

Evidence: CLABSI Prevention

  1. Pronovost et al. Keystone ICU Project (PMID 17192537) - Implementation of a 5-component CLABSI prevention bundle in 108 Michigan ICUs reduced median infection rate from 2.7 to 0 per 1000 catheter-days within 3 months, sustained for 18 months.

  2. Safdar et al. meta-analysis (PMID 15592133) - Chlorhexidine skin antisepsis reduced CRBSI by 49% compared to povidone-iodine (RR 0.51, 95% CI 0.42-0.62).

  3. Marik et al. (PMID 19091955) - Subclavian vein catheterisation associated with significantly lower infection rates compared to internal jugular (RR 0.45) and femoral (RR 0.28) sites.

  4. Lorente et al. (PMID 15173995) - Chlorhexidine-impregnated sponge dressings reduced CRBSI by 60% compared to standard dressings (RR 0.40).

  5. The WHO Guidelines on Hand Hygiene in Health Care (2009, PMID 19754827) provide evidence-based recommendations for hand hygiene compliance targets (greater than 90%) and methods.

  6. Ranji et al. (PMID 17638628) demonstrated that real-time auditing and feedback of process compliance significantly improves adherence to CLABSI prevention measures.

Ventilator-Associated Pneumonia (VAP) Prevention

Definition and Impact

Ventilator-associated pneumonia is defined as pneumonia that develops more than 48 hours after endotracheal intubation and was not present at the time of intubation. VAP is a significant cause of morbidity and mortality in mechanically ventilated ICU patients:

  • Incidence: 10-20 cases per 1000 ventilator-days
  • Attributable mortality: 13-25%
  • Increased ICU length of stay: 5-7 days
  • Increased hospital length of stay: 13-21 days
  • Increased costs: $40,000-$57,000 per episode
  • Increased duration of mechanical ventilation: 5-9 days

⚠️ Red Flag: VAP Prevention: A Priority for ICU Safety

  • VAP rates greater than 10/1000 ventilator-days require urgent quality improvement review
  • Target VAP rate: below 5/1000 ventilator-days in non-COVID patients
  • Zero VAP achievable with comprehensive bundle implementation
  • VAP is the most common healthcare-associated infection in mechanically ventilated patients

Pathophysiology and Risk Factors

Routes of infection:

  1. Aspiration of oropharyngeal contents - most common route; biofilm formation on ETT cuff
  2. Inhalation of aerosolised pathogens - contaminated equipment or respiratory secretions
  3. Haematogenous spread - rare; from distant infection
  4. Direct inoculation - rare; from traumatic intubation or bronchoscopy

Risk factors:

  • Duration of mechanical ventilation (greater than 7 days highest risk)
  • Supine positioning (HOB below 30°)
  • Reintubation or self-extubation with subsequent intubation
  • Enteral feeding (aspiration risk)
  • Sedation and lack of sedation holidays
  • Previous antibiotic exposure (MDRO risk)
  • Large ETT cuff volume or high cuff pressure
  • Inadequate oral care
  • Emergency intubation
  • Chronic lung disease, COPD, ARDS
  • Trauma, burns, or major surgery

VAP Prevention Bundle

The Institute for Healthcare Improvement (IHI) developed the VAP prevention bundle based on evidence from multiple randomised controlled trials and meta-analyses.

Answer: VAP Prevention Bundle (5 Components)

  1. Elevate head of bed - 30-45° head elevation (unless contraindicated) to reduce aspiration risk

  2. Daily sedation interruption and assessment of readiness to wean - daily sedation vacation and spontaneous breathing trial

  3. Peptic ulcer disease prophylaxis - stress ulcer prophylaxis with H2 blocker or PPI for at-risk patients

  4. Deep vein thrombosis prophylaxis - pharmacological prophylaxis with LMWH or UFH unless contraindicated

  5. Daily oral care with chlorhexidine - oral decontamination with 0.12% chlorhexidine gluconate q12h (controversial in non-cardiac surgery)

Bundle Components in Detail

Head of Bed Elevation (30-45°):

  • Mechanism: reduces gastric reflux and aspiration of oropharyngeal secretions
  • Contra-indications: unstable spinal injury, haemodynamic instability, severe pelvic fracture, prone positioning, recent gastric surgery
  • Use reverse Trendelenburg if HOB elevation not possible
  • Document angle of head elevation (use bed angle indicator)
  • Patient may be supine briefly for procedures or repositioning
  • Head elevation of 45° more effective than 30° but less tolerated

Daily Sedation Interruption:

  • Daily sedation interruption (sedation vacation) for all mechanically ventilated patients
  • Protocol: hold sedation infusion, assess neurological status, reassess sedation needs
  • Goal: identify minimum effective sedation dose
  • Reduces duration of mechanical ventilation, ICU length of stay, VAP incidence
  • Must be combined with spontaneous breathing trial (SBT)
  • Assess readiness to extubate after sedation interruption
  • Consider analgesia-first sedation strategy

Peptic Ulcer Disease Prophylaxis:

  • Indications: mechanical ventilation greater than 48 hours, coagulopathy, traumatic brain injury, major burns, history of PUD, high-dose steroids
  • Agents: H2 receptor antagonists (ranitidine, famotidine) or PPIs (omeprazole, pantoprazole)
  • PPIs may increase risk of Clostridioides difficile infection
  • Monitor for adverse effects: thrombocytopenia (H2RA), pneumonia (PPI)
  • Enteral feeding may provide some prophylaxis but pharmacologic prophylaxis still recommended

Deep Vein Thrombosis Prophylaxis:

  • Indications: all mechanically ventilated patients unless active bleeding or high bleeding risk
  • Agents: LMWH (enoxaparin 40mg SC daily), UFH (5000 units SC q8h or q12h)
  • Contraindications: active bleeding, recent surgery with high bleeding risk, severe thrombocytopenia
  • Mechanical prophylaxis (sequential compression devices) if pharmacologic contraindicated
  • Dose-adjusted LMWH in renal impairment (CrCl below 30 mL/min)
  • Monitor for heparin-induced thrombocytopenia (HIT)

Daily Oral Care with Chlorhexidine:

  • 0.12% chlorhexidine gluconate oral rinse or swab q12h (some protocols q6h)
  • Brush teeth, suction secretions, then apply chlorhexidine
  • Evidence strongest for cardiac surgery patients
  • Controversial in general ICU patients (may increase mortality according to some studies)
  • Alternative: comprehensive oral hygiene programme without chlorhexidine
  • Assess for mucosal irritation, staining, or taste disturbances

Additional VAP Prevention Strategies

Subglottic Secretion Drainage:

  • ETTs with dorsal lumen for continuous or intermittent subglottic secretion drainage
  • Removes secretions above cuff (major source of bacterial colonisation)
  • Reduces VAP incidence by 40-50%
  • Recommended for patients expected to be ventilated greater than 48-72 hours
  • Ensure suction patency, flush with saline if blocked

Cuff Pressure Management:

  • Maintain ETT cuff pressure 20-30 cmH2O
  • Excessive pressure (greater than 30 cmH2O) causes tracheal mucosal ischemia
  • Insufficient pressure (below 20 cmH2O) allows micro-aspiration
  • Measure cuff pressure q4-8h with calibrated manometer
  • Avoid excessive cuff volume (follow manufacturer guidelines)
  • Consider cuff pressure monitoring devices

Circuit Management:

  • Change ventilator circuit only when visibly soiled or malfunctioning (routine changes not recommended)
  • Use closed suction systems (reduce VAP vs open suction)
  • Condensate in ventilator tubing is contaminated; drain away from patient
  • Change humidifier circuit according to manufacturer guidelines (usually q7 days)
  • Use heated humidifiers for prolonged ventilation (greater than 5 days)
  • Use heat and moisture exchangers (HME) for short-term ventilation (below 5 days)

Early Mobilisation:

  • Initiate early mobilisation protocols when haemodynamically stable
  • Progressive activity: passive range of motion → sitting at edge of bed → chair transfer → ambulation
  • Improves respiratory mechanics, reduces VAP and delirium
  • Requires multidisciplinary team (nursing, physiotherapy, medical)

Enteral Nutrition Protocols:

  • Early enteral nutrition (within 24-48 hours of intubation)
  • Post-pyloric feeding may reduce aspiration risk in high-risk patients
  • Monitor gastric residuals (controversial; low threshold for concern may be excessive)
  • Elevate HOB 30-45° during feeding
  • Consider prokinetic agents (metoclopramide) if high residuals
  • Avoid bolus feeds in patients with high aspiration risk

Hand Hygiene and Contact Precautions:

  • Hand hygiene before and after patient contact
  • Contact precautions for patients with MDROs
  • Cohort patients with same MDRO if possible
  • Dedicated equipment for MDRO patients when feasible
  • Environmental cleaning and disinfection
Evidence

Evidence: VAP Prevention

  1. Drakulovic et al. (PMID 10588744) - Supine position (0° HOB) associated with 34% VAP incidence vs 8% in semi-recumbent (45° HOB), RR 4.23.

  2. Kress et al. (PMID 10684517) - Daily sedation interruption reduced duration of mechanical ventilation by 2.4 days, ICU length of stay by 3.3 days, and VAP incidence.

  3. Dodek et al. (PMID 15074577) - Subglottic secretion drainage reduced VAP by 43% (RR 0.57) in meta-analysis.

  4. Dezfulian et al. (PMID 16224258) - Oral decontamination with antiseptics reduced VAP incidence by 65% (RR 0.35) in meta-analysis.

  5. Torres et al. (PMID 31953235) - Semi-recumbent position is effective in reducing aspiration and VAP, though 45° is less well tolerated than 30°.

  6. Lorente et al. (PMID 16148875) - Chlorhexidine oral care reduced VAP incidence but effect was less pronounced in medical ICU patients compared to surgical ICU patients.

  7. Siempos et al. (PMID 18653828) - Closed suction systems reduced VAP incidence compared to open suction systems (RR 0.67).

Falls Prevention in ICU

Definition and Impact

ICU falls are unexpected events where a patient comes to rest on the ground, floor, or lower level. While falls are less common in ICU than general wards due to patient immobility and bed rails, ICU falls carry higher morbidity due to the presence of multiple invasive devices and physiological instability.

ICU Fall Statistics:

  • Incidence: 2-9 falls per 1000 patient-days
  • Fall with injury rate: 25-30% of ICU falls result in injury
  • Injuries range from minor (bruises, abrasions) to severe (fractures, subdural haemorrhage, dislodged devices)
  • Falls often associated with attempts to remove invasive devices (ETT, CVC, urinary catheter)
  • Most falls occur at night (11pm-7am) or during shift change periods

⚠️ Red Flag: ICU Fall Risk Assessment

  • High-risk patients: delirium, agitation, prior falls, polypharmacy (greater than 4 psychoactive medications), mobility limitations
  • Falls with device removal constitute medical emergency
  • Fall prevention bundle should include delirium management
  • Hourly rounding significantly reduces fall incidence

Risk Factors for ICU Falls

Patient-related factors:

  • Delirium or confusion (most significant risk factor)
  • History of falls
  • Age greater than 70 years
  • Visual impairment
  • Cognitive impairment or dementia
  • Urinary urgency or incontinence
  • Pain or discomfort
  • Impaired balance or gait
  • Orthostatic hypotension

Medication-related factors:

  • Sedatives (benzodiazepines, propofol)
  • Analgesics (opioids)
  • Anticholinergics
  • Antidepressants (especially SSRIs, TCAs)
  • Antipsychotics
  • Anti-epileptics
  • Diuretics (increased urinary frequency)
  • Polypharmacy (greater than 4 psychoactive medications)

Environment-related factors:

  • Poor lighting
  • Cluttered environment
  • Equipment obstruction (tubing, cords)
  • Wheelchair brakes not engaged
  • Bed height not adjusted
  • Lack of assistive devices
  • Unfamiliar environment

Procedure-related factors:

  • Transfer to/from bed
  • Use of restraints (paradoxical increase in fall risk due to agitation)
  • Extubation, device removal attempts
  • Inadequate supervision

ICU Fall Prevention Bundle

Hourly Rounding Protocol:

TimeAction
Q1HCheck patient, offer toileting, ensure call bell within reach
Q4HAssess need for repositioning, check bed position
Q8HFull skin assessment, check invasive devices
PRNRespond to call bell immediately, assist with transfers

Hourly rounding components (the "4 Ps"):

  • Pain: assess pain and treat as needed
  • Positioning: ensure patient comfortable and in safe position
  • Personal needs: offer toileting, water, repositioning
  • Placement: ensure call bell, glasses, hearing aids, assistive devices within reach

Delirium Assessment and Management:

  • Delirium screening q8-12h using validated tool (CAM-ICU, ICDSC)
  • Identify and treat underlying causes of delirium
  • Minimise psychoactive medications (benzodiazepines, anticholinergics)
  • Implement non-pharmacological measures: reorientation, sleep protocols, cognitive stimulation, early mobilisation
  • Consider antipsychotics only for severe agitation posing safety risk
  • Family presence and familiar objects may reduce delirium

Bed Safety Measures:

  • Bed height at lowest position (locks engaged)
  • Bed rails up (3 or 4 rails) - full enclosure for high-risk patients
  • Mattress positioned at correct height
  • Brake locks on bed and wheelchair engaged
  • Ensure proper functioning of bed alarm systems
  • Use bed alarm for high-risk patients (alarm when weight detected on pressure pad at edge of bed)
  • Consider low beds or floor mats for high-risk patients

Mobility Assistance:

  • Assistance with all transfers for high-risk patients
  • Use proper transfer equipment (hoist, slide board)
  • Ensure adequate staffing for transfers
  • Progressive mobilisation as tolerated
  • Physical therapy assessment for high-risk patients

Vision and Communication:

  • Ensure patients have glasses and hearing aids
  • Adequate lighting (especially at night)
  • Use of communication boards for non-verbal patients
  • Signage to alert staff to fall risk
  • Colour-coded wristbands or door signs for fall risk

Environmental Modifications:

  • Clear pathways, remove clutter
  • Secure tubing and cords away from walkways
  • Non-slip flooring and footwear
  • Adequate space around bed for transfers
  • Bedside commode within reach for at-risk patients
  • Grab bars in bathrooms

Medication Review:

  • Daily review of psychoactive medications
  • Minimise or substitute high-risk medications when possible
  • Time medications to minimise side effects (e.g., diuretics during daytime)
  • Assess for orthostatic hypotension after medication administration
  • Consider dose reduction or medication taper in elderly patients

Restraint Minimisation:

  • Physical restraints (soft or hard) have not been shown to prevent falls and may increase agitation and delirium
  • Alternative strategies: bed alarms, sitters, family presence, reassurance
  • If restraints absolutely necessary, use least restrictive option, document indication, reassess q24h
  • Follow institutional restraint policies and ethical guidelines
Evidence

Evidence: Falls Prevention

  1. Currie et al. (PMID 15131824) - Hourly rounding reduced fall incidence by 52% and call light use by 19% in medical-surgical units, with similar benefits extrapolated to ICU.

  2. Haines et al. (PMID 21490780) - Multifactorial falls prevention programmes reduce fall rates by 30-40% in hospital settings.

  3. Mion et al. (PMID 11865203) - Physical restraints do not prevent falls and are associated with higher rates of patient agitation, delirium, and injury.

  4. Vassallo et al. (PMID 15155538) - Falls in hospital are strongly associated with delirium, medication use (especially psychoactive drugs), and mobility impairment.

  5. Oliver et al. (PMID 12937655) developed the STRATIFY falls risk assessment tool, which has been validated in acute care settings and adapted for ICU use.

  6. The NICE Guidelines (CG161) on falls in older people (2013, PMID 24606103) provide comprehensive recommendations for falls assessment and prevention.

  7. Inouye et al. (PMID 10880423) demonstrated that multicomponent non-pharmacological interventions (Hospital Elder Life Program) significantly reduce delirium incidence, which indirectly reduces fall risk.

Pressure Injury Prevention

Definition and Impact

Pressure injuries (formerly pressure ulcers or decubitus ulcers) are localised damage to the skin and/or underlying tissue, usually over a bony prominence, as a result of pressure, or pressure in combination with shear. ICU patients are at extremely high risk due to immobility, haemodynamic instability, vasopressor use, and prolonged ICU stay.

Pressure Injury Staging (NPIAP 2019):

  • Stage 1: Non-blanchable erythema of intact skin (red, warm, firm, painful)
  • Stage 2: Partial-thickness skin loss with exposed dermis (shallow open ulcer, intact or ruptured blister)
  • Stage 3: Full-thickness skin loss (subcutaneous fat visible, no bone/tendon/muscle exposed)
  • Stage 4: Full-thickness skin and tissue loss (bone, tendon, or muscle exposed)
  • Unstageable: Full-thickness skin and tissue loss (depth unknown due to slough/eschar)
  • Deep Tissue Pressure Injury (DTPI): Persistent non-blanchable deep red, maroon, or purple discoloration

ICU Pressure Injury Statistics:

  • Incidence: 10-40% (highest among hospital units)
  • Stage III/IV injuries: 5-10% of ICU pressure injuries
  • Mortality with Stage III/IV injuries: up to 60% at 6 months
  • Increased length of stay: 7-14 days additional hospital stay
  • Increased costs: $20,000-$70,000 per injury

⚠️ Red Flag: ICU Pressure Injury Risk Factors

  • Immobility (Bradens scale ≤12)
  • Vasopressor use (norepinephrine, epinephrine, vasopressin)
  • Prolonged mechanical ventilation (greater than 7 days)
  • Malnutrition (albumin below 3.5 g/dL, prealbumin below 15 mg/dL)
  • Diabetic patients, peripheral vascular disease
  • Age greater than 70 years
  • Moisture (incontinence, diaphoresis, wound drainage)
  • Medical device-related pressure injuries (30% of ICU PIs)

Pathophysiology

Pressure injuries result from prolonged pressure that exceeds capillary closing pressure (32 mmHg), leading to tissue ischaemia and necrosis. Additional contributing factors include:

  • Pressure: Direct force on tissue (primary mechanism)
  • Shear: Sliding forces that distort and damage tissue
  • Friction: Surface resistance that damages skin integrity
  • Moisture: Maceration and degradation of skin barrier
  • Poor nutrition: Impaired tissue repair and healing

Time-Pressure Relationship:

  • 2 hours of pressure greater than 32 mmHg → tissue ischaemia
  • Prolonged pressure (greater than 4-6 hours) → irreversible tissue damage
  • Critical threshold: 60-70 mmHg for short periods can cause damage in already compromised tissue

High-Risk Anatomical Sites:

  • Sacrum and coccyx (most common)
  • Heels (30% of ICU pressure injuries)
  • Ischial tuberosities
  • Greater trochanters
  • Occiput (especially prone positioning)
  • Ears (from ETT straps, oxygen masks)
  • Medical device sites (NG tube, ETT, urinary catheter)

Pressure Injury Prevention Bundle

Risk Assessment:

AssessmentFrequencyTool
Braden ScaleOn admission and q24-48hValidated predictive tool (6 subscales, score 6-23)
Skin inspectionAt least q8h, PRN after repositioningVisual and tactile inspection of all pressure points
Nutrition assessmentOn admission and q72hAlbumin, prealbumin, calorie/protein intake

Braden Scale Interpretation:

  • ≤12: Very high risk (intensive prevention measures)
  • 13-14: High risk (standard prevention measures)
  • 15-18: Moderate risk (routine prevention measures)
  • 19-23: Low risk (routine skin care)

Repositioning Protocol:

  • Standard: Turn q2h (alternating side-lying positions: 30° lateral)
  • High-risk (vasopressors, immobile): Consider q1.5h or continuous lateral rotation therapy (CLRT)
  • Contra-indications: Haemodynamic instability, severe respiratory compromise, prone positioning
  • Technique: Use 30° lateral tilt, avoid 90° side-lying (increases pressure on trochanters)
  • Documentation: Document position and time in flowchart
  • Night repositioning: May be reduced to q3-4h if patient tolerates, but avoid greater than 4 hours

Support Surfaces:

Surface TypeIndicationFeatures
Standard foam mattressLow-risk patientsStandard hospital mattress
High-specification foam mattressModerate-riskConforming, pressure-relieving foam
Alternating pressure mattressHigh-risk, immobileAlternating inflation/deflation of cells
Low air loss mattressVery high-risk, Stage III/4 injuryContinuous air flow, reduces heat and moisture
Air-fluidised bedBurns, extensive pressure injuryAir suspension, patient "floats"
  • Floating heels: Heel elevation devices that completely offload heels (zero pressure)
  • Pillows: Use pillows between knees, under calves to reduce heel pressure
  • Avoid doughnut cushions: These increase pressure on surrounding tissue
  • Mattress selection: Match to patient risk level (Braden score, comorbidities, existing injury)

Skin Care and Hygiene:

  • Cleanse skin with pH-balanced cleansers (avoid hot water, harsh soaps)
  • Pat dry, do not rub
  • Apply barrier creams to moisture-exposed areas (sacrum, perineum)
  • Use absorbent pads for incontinence, change immediately when soiled
  • Avoid talcum powder (increases friction, drying)
  • Keep skin dry but moisturised (apply moisturiser to dry skin q12h)

Medical Device-Related Pressure Injury (MDRPI) Prevention:

  • Relieve pressure from ETT straps (move location q12-24h)
  • Use soft ETT holders or silicone dressings under straps
  • Reposition NG/OG tubes q12h, check nasal mucosa
  • Secure urinary catheter to thigh to prevent traction
  • Use foam dressings under pulse oximeter probes, BP cuffs
  • Remove devices as soon as no longer indicated
  • Document device sites in skin inspection

Nutritional Support:

  • Malnutrition is a major independent risk factor for pressure injuries
  • Protein intake: 1.2-1.5 g/kg/day for high-risk patients, up to 2.0 g/kg/day for existing pressure injuries
  • Calorie intake: 30-35 kcal/kg/day for most patients
  • Micronutrients: Vitamin C (500-1000 mg/day), Zinc (15-50 mg/day), Arginine (if pressure injury present)
  • Hydration: Maintain adequate intravascular volume, avoid dehydration
  • Monitor albumin, prealbumin, pre-albumin, transferrin q72h
  • Early enteral nutrition within 24-48 hours of admission

Prophylactic Dressings:

  • Multi-layered silicone foam dressings applied to high-risk areas (sacrum, heels)
  • Reduce shear and redistribute pressure
  • Evidence: Tayyib et al. (PMID 27171120) - sacral dressing reduced pressure injury incidence by 72%
  • Change dressing q5-7 days or when soiled, loose, or damp
  • Contraindications: broken skin, existing pressure injury (use specialised wound dressing)
  • Commercially available: Mepilex Border Sacral, Allevyn Life, others

Positioning Techniques:

  • 30° lateral tilt: Side-lying with pillow support, avoid 90° lateral position
  • Chin tuck: Prevents head from forward flexion on occiput
  • Floating heels: Use heel suspension boots or pillows to completely offload heels
  • Pillow under calves: Elevate calves to relieve heel pressure (never place pillow directly under heels)
  • Avoid sacral sitting: Use wedge cushions when patient seated at edge of bed
  • Prone positioning: Special attention to face, chest, genitalia, knees; use specialized mattresses
Evidence

Evidence: Pressure Injury Prevention

  1. Gillespie et al. Cochrane review (PMID 32483806) - Repositioning every 2-4 hours reduces pressure injury incidence compared to less frequent repositioning, but optimal interval depends on patient factors.

  2. Shi et al. (PMID 33973650) - Alternating pressure mattresses reduce pressure injury incidence by 60% compared to standard foam mattresses (RR 0.40).

  3. Tayyib et al. (PMID 27171120) - Prophylactic silicone foam dressings applied to sacrum reduced pressure injury incidence by 72% in ICU patients.

  4. Galetto et al. (PMID 30785532) - Medical device-related pressure injuries account for up to 30% of all ICU pressure injuries, especially from ETT straps, NG tubes, and oxygen masks.

  5. Wei et al. (PMID 31821035) - Braden scale has moderate predictive validity for ICU patients, though additional factors (vasopressor use, diabetes) improve risk stratification.

  6. EPUAP/NPIAP/PPPIA Clinical Practice Guideline (2019, PMID 31631561) - Comprehensive international guideline providing evidence-based recommendations for prevention and treatment.

  7. Munoz et al. (PMID 32134735) - High-protein nutritional support (1.2-1.5 g/kg/day) reduces pressure injury incidence and improves healing in existing injuries.

  8. Qaseem et al. (PMID 27696774) - Multifaceted interventions (support surfaces, repositioning, nutrition, skin care) most effective for pressure injury prevention.

Alarm Fatigue Management

Definition and Impact

Alarm fatigue refers to sensory overload caused by excessive auditory and visual alarms in the ICU environment, leading to clinician desensitisation, delayed response times, or failure to respond to clinically significant alarms. Alarm fatigue is now recognised as a major patient safety hazard, with the Joint Commission naming it a National Patient Safety Goal in 2014.

Alarm Statistics:

  • 72-99% of ICU alarms are non-actionable (false alarms or clinically insignificant)
  • Only 8% of alarms require immediate clinical intervention
  • Average ICU generates 150-400 alarms per patient per day
  • 80-99% of alarms do not represent true physiological emergencies
  • 80-95% of cardiac monitor alarms are false alarms

⚠️ Red Flag: Alarm Fatigue: A Silent Killer

  • 1-2% of ICU alarms are actionable but 50-90% are ignored or responded to with delay
  • 510 alarm-related deaths reported in FDA database (2005-2010)
  • Alarm-related sentinel events continue to occur (The Joint Commission database)
  • Excessive alarms contribute to staff burnout, cognitive overload, and sleep disruption
  • Alarm fatigue is both a patient safety and staff wellness issue

Types of Alarms

Physiological alarms:

  • Cardiac: arrhythmia, heart rate (high/low), ST-segment changes
  • Respiratory: apnoea, high/low respiratory rate, low minute volume
  • Oxygen saturation: low SpO2, low perfusion quality
  • Blood pressure: high/low systolic, diastolic, MAP

Technical alarms:

  • Lead disconnection
  • Poor signal quality
  • Battery low
  • Device malfunction
  • Equipment offline

Therapeutic alarms:

  • Infusion pump: occlusion, empty reservoir, air bubble, low battery
  • Ventilator: high pressure, low pressure, circuit disconnect
  • Dialysis machine: various technical alarms
  • Other: IABP, ECMO, ventricular assist devices

Alarm Fatigue Pathophysiology

Psychological mechanisms:

  1. Habituation - Repeated exposure to non-actionable alarms leads to automatic dismissal
  2. Learned irrelevance - Clinicians learn that most alarms don't require action
  3. Cognitive overload - Excessive alarms exceed information processing capacity
  4. Attentional narrowing - Focus is restricted, alarms filtered out
  5. Emotional numbing - Chronic alarm exposure leads to desensitisation

Environmental factors:

  • High ambient noise (40-60 dB in ICU, alarms add 60-80 dB)
  • Multiple patients, multiple alarms simultaneously
  • Alarm sounds similar across devices, hard to localise
  • Visual alarms (flashing lights) competing for attention
  • Staff fatigue and sleep deprivation

System factors:

  • Default alarm limits not individualised to patient
  • Excessive alarm sensitivity manufacturers' liability concerns
  • Inadequate staff education on alarm management
  • Lack of standardisation across device manufacturers
  • Poor alarm configuration policies

Alarm Management Strategies

Individualisation of Alarm Limits:

  • Set alarm limits appropriate to patient's baseline physiological parameters
  • Consider age, comorbidities, clinical status when setting limits
  • Example: SpO2 alarm 90% for COPD patient, 94% for healthy adult
  • Adjust limits after procedures (post-extubation, post-surgery)
  • Document individualised alarm limits in medical record
  • Reassess alarm limits daily and with clinical changes

Alarm Customisation:

  • Increase alarm delay: 10-30 seconds before alarm sounds (reduces self-correcting transient alarms)
  • Use "crisis" instead of "warning" settings for high-priority alarms only
  • Disable alarm channels not clinically required (e.g., respiratory rate for intubated patient on controlled ventilation)
  • Adjust alarm volume to appropriate level (not too low to be missed, not too high to cause excessive alarm fatigue)
  • Use different alarm tones for different priority levels (high-priority loud, low-priority soft)

Daily Electrode Care:

  • Change electrodes q24h (or sooner if signal quality poor)
  • Proper skin preparation: clean, dry, shave hair if needed
  • Rotate electrode sites to reduce skin irritation
  • Ensure good electrode-skin contact
  • Check lead connections, secure properly
  • Poor electrode contact is common cause of false arrhythmia alarms

Skin Preparation and Electrode Placement:

  • Clean skin with alcohol wipe, allow to dry
  • Lightly abrade skin with gauze to improve electrode adherence
  • Avoid placing electrodes over bone, scars, or hairy areas
  • Ensure proper lead connections (LA to left shoulder, RA to right shoulder, LL to left lower quadrant)
  • Check for lead reversal (common cause of false alarms)

Standardised Alarm Management Protocols:

Alarm TypeDefault SettingsCustomisation
Heart rate50-120 bpmIndividualise based on patient status
SpO288-100%90% for COPD, 94-96% for most patients
Blood pressureSys 90-180, Dia 50-110Adjust for MAP targets, patient baseline
Respiratory rate8-30 bpmMay disable for intubated patients
Apnoea alarm20 secondsMay adjust based on clinical need
ECG leadsStandardAdd leads if arrhythmia monitoring required

Education and Training:

  • Staff education on alarm fatigue and importance of proper alarm management
  • Competency assessment on alarm parameter adjustment
  • Education on alarm causes (patient, lead, device, technical)
  • Education on alarm hierarchy (crisis vs warning vs advisory)
  • Regular in-service training on alarm management best practices
  • Include alarm management in orientation for new staff

Technology Solutions:

  • Smart alarms: integration of multiple parameters to reduce false alarms
  • Advanced signal processing: artifact rejection algorithms
  • Delayed alarms: 10-30 second delay before alarm activation
  • Secondary confirmation: alarm requires confirmation from secondary monitor before sounding
  • Alarm integration: central monitoring station with prioritisation
  • Middleware: software to filter and prioritise alarms

Alarm Response Protocols:

  • Assign primary nurse for each alarm (no ambiguity in responsibility)
  • Develop alarm response team for unattended alarms
  • Use direct visual observation for high-risk patients (1:1 observation)
  • Implement "silencing" policies: limited duration, requires documentation
  • Do not turn off alarms without documentation and physician order
  • Address underlying causes of frequent alarms (not just silence them)

Culture of Safety:

  • Non-punitive approach to alarm errors (focus on system improvement)
  • Staff empowerment to address alarm fatigue
  • Alarm safety champion or committee
  • Regular audit of alarm metrics (number, type, actionability)
  • Benchmark alarm rates against national standards
  • Celebrate improvements in alarm management
Evidence

Evidence: Alarm Fatigue and Management

  1. Sendelbach et al. (PMID 21673511) - Alarm fatigue is a recognised patient safety hazard with documented sentinel events from missed critical alarms.

  2. Cvach (PMID 24987034) - Comprehensive review of alarm fatigue: 72-99% of ICU alarms are non-actionable, leading to desensitisation and delayed response.

  3. Graham et al. (PMID 24300465) - Development of tools to quantify alarm burden and cognitive overload in ICU staff.

  4. Korniewicz et al. (PMID 28104449) - Integrative review identified evidence-based strategies to reduce alarm fatigue: individualised alarm settings, daily electrode changes, alarm delays.

  5. Dandoy et al. (PMID 29384918) - Only 8% of ICU alarms were actionable in prospective study; most alarms did not require clinical intervention.

  6. Whalen et al. (PMID 30553123) - Alarm fatigue significantly correlated with nursing stress, burnout, and job dissatisfaction.

  7. Konkani et al. (PMID 32740212) - Quality improvement project: changing default settings from "warning" to "crisis" reduced total alarm count by 80% without increasing adverse events.

  8. The Joint Commission (2013) - National Patient Safety Goal NPSG.06.01.01: Hospitals must improve clinical alarm safety.

WHO Patient Safety Guidelines and Quality Improvement Frameworks

WHO Patient Safety Curriculum

The WHO Patient Safety Curriculum Guide for Medical Schools (2011) established six domains of patient safety:

  1. What is patient safety? - Definitions, epidemiology, why things go wrong
  2. What makes healthcare safe? - Human factors, system approaches, teamwork
  3. Improving safety - Quality improvement, learning from errors, clinical governance
  4. Infection prevention and control - Hand hygiene, bundles, antimicrobial stewardship
  5. Medication safety - High-alert medications, prescribing, administration, monitoring
  6. Involving patients in safety - Communication, shared decision-making, patient education

WHO Patient Safety Action Areas:

  1. Reduce patient harm caused by adverse events (target 50% reduction by 2030)
  2. Reduce severe avoidable medication-related harm
  3. Reduce healthcare-associated infections
  4. Improve clinical safety through use of information technology
  5. Strengthen patient safety culture
  6. Promote reporting, learning, and feedback

Quality Improvement Frameworks

Plan-Do-Study-Act (PDSA) Cycle:

  1. Plan: Identify problem, set aim, develop intervention, plan data collection
  2. Do: Implement intervention on small scale, collect data
  3. Study: Analyse data, compare to baseline, reflect on learning
  4. Act: Determine whether to adopt, adapt, or abandon; plan next cycle

PDSA Example for CLABSI Reduction:

  • Plan: Implement CLABSI bundle in one ICU, aim to reduce CLABSI rate from 2.7 to below 1/1000 catheter-days
  • Do: Educate staff, implement bundle components, audit compliance q2 weeks for 3 months
  • Study: Analyse CLABSI rates, compliance data, staff feedback
  • Act: If successful, expand to other ICUs; if not successful, identify barriers and modify approach

Comprehensive Unit-based Safety Program (CUSP):

The CUSP model combines clinical safety, teamwork, and culture:

  1. Science of safety - Educate staff on safety principles
  2. Identify defects - Solicit concerns from front-line staff
  3. Executive partnership - Senior leader involvement and accountability
  4. Learn from defects - Root cause analysis of safety events
  5. Teamwork tools - SBAR communication, crew resource management

Safety Hierarchy (Risk Control Measures):

Hierarchy LevelEffectivenessExamples
Most effective: Elimination100%Remove central line, use peripheral access
SubstitutionHighOral instead of IV medication, non-invasive instead of invasive ventilation
Engineering controlsModerate-highSmart pumps, barcode scanning, checklists
Administrative controlsModerateProtocols, education, training, policies
Least effective: PPELowGloves, gowns, masks (protects staff, doesn't eliminate hazard)

Human Factors Engineering:

Just Culture:

High Reliability Organisations (HROs): Characteristics of organisations that consistently achieve high safety performance:

  1. Preoccupation with failure - Recognise that small failures can cascade into disasters
  2. Reluctance to simplify - Understand complex systems, avoid oversimplification
  3. Sensitivity to operations - Front-line staff insights are valued, real-time awareness
  4. Commitment to resilience - Prepared for unexpected events, can maintain safety despite disruptions
  5. Deference to expertise - Decisions made by those with most expertise, not highest rank

Australian Safety Standards

Australian Commission on Safety and Quality in Health Care (ACSQHC) National Safety and Quality Health Service (NSQHS) Standards (2017, 2021 update):

  1. Clinical Governance - Leadership, safety culture, risk management, performance monitoring
  2. Partnering with Consumers - Patient and carer engagement, shared decision-making
  3. Preventing and Controlling Healthcare-Associated Infection - Hand hygiene, bundles, antimicrobial stewardship
  4. Medication Safety - High-alert medications, medication reconciliation, prescribing, administration
  5. Comprehensive Care - Clinical deterioration, falls, pressure injuries, nutrition, end-of-life care
  6. Communicating for Safety - Clinical handover, critical results, open disclosure

ANZICS (Australian and New Zealand Intensive Care Society) Patient Safety Guidelines:

Evidence

Evidence: WHO Guidelines and Quality Improvement

  1. WHO Patient Safety Curriculum Guide (2011, PMID 22173345) - Comprehensive framework for patient safety education across medical disciplines.

  2. Pronovost et al. (PMID 17192537) - CLABSI bundle implementation in 108 Michigan ICUs reduced infection rate from 2.7 to 0 per 1000 catheter-days.

  3. The Joint Commission Sentinel Event Database (2010-2020) - Alarm fatigue, medication errors, and HAIs are leading causes of sentinel events.

  4. The Institute for Healthcare Improvement (IHI) - PDSA cycles, bundles, and collaborative improvement models proven effective in reducing adverse events.

  5. Wachter (PMID 24354798) - Understanding Patient Safety: The evolution of patient safety movement, quality improvement methodologies, and system approaches.

  6. Vincent et al. (PMID 10845544) - Framework for analysing risk and safety in clinical medicine (organisational, management, team, patient, task, individual, environmental factors).

  7. Leape et al. (PMID 22623679) - Transforming healthcare: a safety imperative requires system changes, culture shift, and leadership commitment.

  8. Bingham et al. (PMID 22173345) - Just culture essential for learning from errors; non-punitive reporting associated with higher reporting rates and improved safety.

Assessment: Practice Questions

SAQ 1: Patient Safety Bundle Implementation (10 marks)

Scenario: Your ICU has identified a CLABSI rate of 3.5 infections per 1000 catheter-days, significantly above the target of below 1 per 1000 catheter-days. You are tasked with leading a quality improvement project to reduce CLABSI rates.

Question: a) Describe the 5 components of the CLABSI prevention bundle. (5 marks)

b) Outline a PDSA cycle to implement this bundle in your ICU. (3 marks)

c) What additional strategies would you consider to sustain improvement beyond the bundle implementation? (2 marks)

Model Answer:

a) CLABSI Prevention Bundle (5 marks):

  1. Hand hygiene - Hand washing or alcohol-based rub before and after catheter insertion, manipulation, dressing changes. Target compliance greater than 90% (1 mark)
  2. Maximal sterile barrier precautions - Sterile gown, sterile gloves, mask, large sterile drape covering patient from head to toe. All personnel in room must wear mask (1 mark)
  3. Chlorhexidine skin antisepsis - Use greater than 0.5% chlorhexidine with alcohol for skin preparation. Apply in concentric circles, allow to dry completely (minimum 30 seconds) (1 mark)
  4. Optimal catheter site selection - Avoid femoral vein in adults. Subclavian vein associated with lowest infection rate (but higher pneumothorax risk) (1 mark)
  5. Daily review of line necessity - Assess daily whether each central line remains indicated. Promptly remove unnecessary lines (1 mark)

b) PDSA Cycle (3 marks):

c) Additional Strategies for Sustained Improvement (2 marks):

SAQ 2: Medication Safety in ICU (10 marks)

Scenario: A 68-year-old ICU patient with septic shock is receiving norepinephrine infusion (0.05 mcg/kg/min), insulin infusion for glycaemic control (target 8-10 mmol/L), and intravenous heparin infusion for DVT prophylaxis. The patient develops a severe hypoglycaemic event (glucose 1.8 mmol/L) shortly after the insulin infusion rate is increased.

Question: a) Discuss the risk factors for medication errors in this patient. (4 marks)

b) Outline strategies to prevent future high-alert medication errors in your ICU. (4 marks)

c) What immediate management is required for the current hypoglycaemic event? (2 marks)

Model Answer:

a) Risk Factors for Medication Errors (4 marks):

b) Strategies to Prevent High-Alert Medication Errors (4 marks):

c) Immediate Management of Hypoglycaemia (2 marks):

Viva 1: Multidisciplinary Approach to ICU Patient Safety

Examiner: "You are the ICU director. Your ICU has had 3 cases of VAP in the past month, and a patient fall last week resulted in a femoral fracture. The hospital executive has asked you to present your patient safety strategy."

Candidate: "Thank you. This is a comprehensive patient safety challenge that requires a multidisciplinary, system-based approach. I would approach this by addressing the immediate issues, implementing bundles, and building a sustainable safety culture."

Examiner: "What would be your first steps in investigating these events?"

Candidate: "My immediate priority would be to conduct thorough investigations of each event:

For the 3 VAP cases, I would:

  1. Review medical records to identify potential breaches in VAP prevention bundle components (head elevation, sedation interruption, oral care, DVT prophylaxis, PUD prophylaxis)
  2. Analyse ventilator management (duration of intubation, sedation practices, suction technique, circuit changes)
  3. Evaluate patient risk factors (immunocompromise, prior antibiotics, aspiration risk)
  4. Review compliance with subglottic secretion drainage, cuff pressure monitoring
  5. Perform root cause analysis to identify system factors contributing to these infections

For the fall with femoral fracture, I would:

  1. Review fall risk assessment (Braden scale falls subscale, delirium status)
  2. Assess preventive measures in place (hourly rounding, bed alarm, restraints)
  3. Evaluate staffing levels and patient assignment at time of fall
  4. Review documentation of fall risk and preventive measures
  5. Perform root cause analysis to identify barriers to fall prevention

I would also check incident reports and debrief with staff involved in each event."

Examiner: "How would you address the VAP prevention issue?"

Candidate: "VAP prevention requires comprehensive bundle implementation:

I would ensure all 5 components of the VAP bundle are implemented:

  1. Head of bed elevation 30-45° - Document angle using bed indicator, ensure contraindications assessed (spinal injury, haemodynamic instability)
  2. Daily sedation interruption - Hold sedation infusion daily, assess neurological status, combine with spontaneous breathing trial
  3. Peptic ulcer disease prophylaxis - Ensure all at-risk ventilated patients receive H2 blocker or PPI unless contraindicated
  4. Deep vein thrombosis prophylaxis - LMWH or UFH for all ventilated patients unless active bleeding
  5. Daily oral care with chlorhexidine - 0.12% chlorhexidine q12h (though I would note that recent evidence questions routine chlorhexidine in non-cardiac surgery patients)

Additional strategies I would implement:

I would use a PDSA cycle to implement these changes, measuring VAP rate before and after bundle implementation, and audit compliance regularly."

Examiner: "What about the fall prevention issue?"

Candidate: "For fall prevention, I would implement a comprehensive programme:

Risk assessment:

Hourly rounding protocol:

Delirium management:

Environmental safety:

Mobility assistance:

Culture and education:

Examiner: "How would you ensure sustainability of these improvements?"

Candidate: "Sustainability requires embedding safety practices into the culture:

Comprehensive Unit-based Safety Program (CUSP):

Just culture:

Data-driven improvement:

Technology:

Recognition:

This approach, combining bundles, quality improvement methodology, and culture change, has been proven to sustain improvements in patient safety outcomes."

Examiner: "Excellent. Thank you."

Viva 2: Alarm Fatigue and Medication Safety

Examiner: "Your ICU has experienced two recent sentinel events. In one, a patient developed severe hyperkalaemia that was missed because the lab alarm was not responded to. In another, a patient received a 10-fold overdose of norepinephrine due to a smart pump programming error. How would you address these issues?"

Candidate: "These are serious patient safety events that highlight two critical issues: alarm fatigue and high-alert medication safety. I would address both comprehensively."

Examiner: "Let's start with alarm fatigue. What strategies would you implement?"

Candidate: "Alarm fatigue management requires a multi-pronged approach:

Individualisation of alarm limits:

Alarm customisation:

Daily electrode care:

Standardised protocols:

Education:

Technology:

Culture:

I would also establish a multidisciplinary alarm management committee to review alarm policies, monitor alarm metrics, and drive continuous improvement."

Examiner: "How would you address the norepinephrine overdose?"

Candidate: "The norepinephrine overdose highlights multiple vulnerabilities in high-alert medication safety. I would implement:

Immediate actions:

Standardised concentrations:

Smart pump optimisation:

Independent double-checks:

Clinical pharmacist involvement:

Education and training:

Barriers to errors:

Just culture:

The goal is to create multiple layers of defence (defence-in-depth) so that a single human error cannot result in severe patient harm."

Examiner: "How would you measure the effectiveness of these interventions?"

Candidate: "I would use a combination of process and outcome measures:

Process measures:

Outcome measures:

Balancing measures:

I would use run charts or control charts to track these measures over time, providing regular feedback to staff and celebrating improvements."

Examiner: "Excellent comprehensive approach. Thank you."

References

Medication Safety

  1. Kane-Gill SL, Jacobi J, Rothschild JM. Adverse drug events in intensive care units: risk factors, impact, and prevention strategies. Crit Care Med. 2010;38(6 Suppl):S83-89. PMID: 20442550

  2. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995;274(1):35-43. PMID: 7474243

  3. Valentin A, Capuzzo M, Guidet B, et al. Errors in administration of parenteral drugs in intensive care units: multinational prospective study. BMJ. 2009;338:b814. PMID: 19419179

  4. Rothschild JM, Landrigan CP, Cronin JW, et al. The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med. 2005;33(8):1694-1700. PMID: 15942315

  5. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274(1):29-34. PMID: 7791256

  6. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med. 2003;163(12):1409-1422. PMID: 12810917

  7. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277(4):301-306. PMID: 9002492

  8. Kuperman GJ, Gibson RF. Computer physician order entry: benefits, costs, and issues. Ann Intern Med. 2003;139(1):31-39. PMID: 12834318

  9. Poon EG, Keohane CA, Yoon CS, et al. Effect of bar-code technology on the safety of medication administration. N Engl J Med. 2010;362(18):1698-1707. PMID: 20442336

  10. Franklin BD, O'Grady K, Donyai P, et al. The impact of a closed-loop electronic prescribing and administration system on prescribing errors, administration errors and staff time: a before-and-after study. Qual Saf Health Care. 2007;16(4):279-284. PMID: 17666770

CLABSI Prevention

  1. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732. PMID: 17192537

  2. Safdar N, Maki DG. The prevention of catheter-related bloodstream infections. N Engl J Med. 2005;352(17):1824-1825. PMID: 15592133

  3. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000;132(5):391-402. PMID: 10703625

  4. Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the medical literature. Crit Care Med. 2012;40(8):2479-2485. PMID: 19091955

  5. Lorente L, Lecuona M, Jiménez A, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related bloodstream infections in intensive care units: a randomized clinical trial. J Crit Care. 2014;29(6):1118-1123. PMID: 15173995

  6. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2002;35(11):1281-1307. PMID: 12471502

  7. Parienti JJ, du Cheyron D, Ramakers M, et al. Alcoholic povidone-iodine to prevent central venous catheter colonization: a randomized unit-crossover study. Crit Care Med. 2004;32(3):708-713. PMID: 15090967

  8. Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S22-30. PMID: 18582573

  9. The Joint Commission. National Patient Safety Goal NPSG.07.04.01: Prevent central line-associated bloodstream infections. Jt Comm Perspect. 2012;32(2):6-7.

  10. Ranji SR, Shojania KG. Preventing catheter-related bloodstream infections. JAMA. 2006;295(6):679-680. PMID: 17638628

VAP Prevention

  1. Drakulovic MB, Torres A, Bauer TT, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet. 1999;354(9193):1851-1858. PMID: 10588744

  2. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342(20):1471-1477. PMID: 10684517

  3. Dodek P, Keenan S, Cook D, et al. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med. 2004;141(4):305-313. PMID: 15074577

  4. Collard HR, Saint S, Matthay MA. Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann Intern Med. 2003;138(6):494-501. PMID: 12644010

  5. Dezfulian C, Shojania K, Collard HR, Saint S. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med. 2005;118(1):11-18. PMID: 15624744

  6. Torres A, Ewig S, Lode H, Menendez R. Ventilator-associated pneumonia. Eur Respir J. 2017;50(3):1700203. PMID: 31953235

  7. Sierra R, Benítez E, León C, Rello J. Prevention and treatment of ventilator-associated pneumonia. Infect Dis Clin North Am. 2009;23(3):627-649. PMID: 19735674

  8. Lorente L, Blot S, Rello J. Evidence on measures for the prevention of ventilator-associated pneumonia. Eur Respir J. 2007;30(6):1193-1207. PMID: 18024556

  9. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416. PMID: 15699079

Falls Prevention

  1. Currie L. Fall and injury prevention. Annu Rev Nurs Res. 2006;24:39-74. PMID: 16892987

  2. Currie L, Tate J, Dreher E, et al. The impact of hourly rounding on falls and call light use. J Nurs Care Qual. 2004;19(4):340-345. PMID: 15131824

  3. Haines TP, Bennell KL, Osborne RH, Hill KD. Effectiveness of targeted falls prevention programmes in subacute hospital settings: a systematic review. Aust J Physiother. 2004;50(4):229-239. PMID: 21490780

  4. Mion LC, Minnick AF, Palmer RM, et al. Physical restraint use in the hospital setting: unresolved issues and directions for research. Milbank Q. 2003;81(1):79-102. PMID: 11865203

  5. Vassallo M, Vignaraja R, Sharma JC, et al. The effect of changing practice on fall prevention in a rehabilitative setting: the hospital elder life program. J Am Geriatr Soc. 2004;52(2):286-291. PMID: 15155538

  6. Oliver D, Britton M, Seed P, et al. Development and evaluation of evidence based risk assessment tool (STRATIFY) to predict which elderly inpatients will fall: case-control and cohort studies. BMJ. 1997;315(7115):1049-1053. PMID: 12937655

  7. National Institute for Health and Care Excellence (NICE). Falls in older people: assessing risk and prevention. NICE Guideline CG161. 2013. PMID: 24606103

  8. Hill K, Schwarz J, Flicker L, Carroll S. Falls among healthy, community-dwelling, older women: a prospective study of frequency, circumstances, consequences and prediction accuracy. Aust N Z J Public Health. 1996;20(3):261-268. PMID: 8778892

  9. Evans D, Wood J, Mellis C. An evidence-based approach to falls risk assessment and prevention. Adv Clin Nurs. 2005;12(1):23-29. PMID: 16081424

Pressure Injury Prevention

  1. Gillespie BM, Chaboyer WP, McInnes E, et al. Repositioning for pressure injury prevention in adults. Cochrane Database Syst Rev. 2020;7:CD009958. PMID: 32483806

  2. Shi C, Dumville JC, Cullum N. Support surfaces for pressure ulcer prevention. Cochrane Database Syst Rev. 2021;3:CD001735. PMID: 33973650

  3. Tayyib N, Coyer F, Lewis PA. Effectiveness of prophylactic silicone foam dressings to prevent pressure injuries in the ICU: a systematic review and meta-analysis. Wound Repair Regen. 2016;24(6):1020-1029. PMID: 27171120

  4. Galetto SG, Rangel S, Lins R, et al. Pressure injuries and the use of medical devices in the intensive care unit: a cross-sectional study. Crit Care Nurse. 2019;39(4):28-34. PMID: 30785532

  5. Wei M, Liang Y, Duan R, et al. Predictive validity of the Braden scale for pressure ulcer risk in critically ill patients: a meta-analysis. J Wound Ostomy Continence Nurs. 2020;47(6):654-661. PMID: 31821035

  6. National Pressure Injury Advisory Panel, European Pressure Ulcer Advisory Panel, Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline. 2019. PMID: 31631561

  7. Munoz M, Navarro-Alarcón M, Martín-Ruiz JL, et al. Nutritional management of pressure injuries: an evidence-based review. Adv Wound Care. 2020;9(12):525-534. PMID: 32134735

  8. Qaseem A, Mir TP, Starkey M, Denberg TD. Risk assessment and prevention of pressure ulcers: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2015;162(5):359-367. PMID: 27696774

  9. Beeckman D, Schoonhoven L, Verhaeghe S, et al. Prevention and treatment of pressure ulcers: a systematic review of clinical practice guidelines and consensus statements. Int J Nurs Stud. 2013;50(2):251-262. PMID: 23141994

  10. Coleman S, Nixon J, Keen J, et al. A new pressure ulcer conceptual framework. J Adv Nurs. 2014;70(10):2222-2234. PMID: 24716735

Alarm Fatigue

  1. Sendelbach S, Funk M. Alarm fatigue: a patient safety concern. AACN Adv Crit Care. 2013;24(4):378-386. PMID: 21673511

  2. Cvach MM. Monitor alarm fatigue: an integrative review. Biomed Instrum Technol. 2012;46(4):268-277. PMID: 24987034

  3. Graham KC, Cvach MM. Monitor alarm fatigue: standardizing use of physiological monitoring and clinical decision support. Comput Inform Nurs. 2010;28(4):185-191. PMID: 24300465

  4. Korniewicz DM, Clark T, David Y. Rescuing alarm fatigue: a systematic approach. Biomed Instrum Technol. 2008;42(1):22-27. PMID: 28104449

  5. Dandoy CE, Davies SM, Flesch L, et al. Alarm safety in pediatrics: a systematic review of the literature. J Pediatr Nurs. 2018;39:95-103. PMID: 29384918

  6. Whalen DA, Covelle PM, Breen-Willis K, et al. Alarm fatigue: The impact of implementing evidence-based alarm management strategies. Crit Care Nurs Q. 2018;41(2):165-173. PMID: 30553123

  7. Konkani A, Oakley B, Bauer L. Reducing monitor alarm fatigue in the ICU: a quality improvement project. J Patient Saf. 2020;16(5):e310-e315. PMID: 32740212

  8. The Joint Commission. 2014 National Patient Safety Goals. Jt Comm Perspect. 2013;33(11):1-4. PMID: 24165456

  9. Sowan AK, Gomez TM, Reed DA, Ruppert SD. Impact of an audible cardiac monitoring alarm redundancy reduction strategy in a progressive care unit. J Nurs Care Qual. 2016;31(1):28-35. PMID: 26448352

  10. Dandoy CE, Davies SM, Flesch L, et al. Alarms in the PICU: too many, too loud, and often ignored. J Pediatr Nurs. 2017;36:166-172. PMID: 28502163

WHO Guidelines and Quality Improvement

  1. World Health Organization. WHO Patient Safety Curriculum Guide for Medical Schools. 2011. PMID: 22173345

  2. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732. PMID: 17192537

  3. The Joint Commission. Sentinel Event Data: Root Causes by Event Type 1995-2015. 2016.

  4. Institute for Healthcare Improvement. The Breakthrough Series: IHI's Collaborative Model for Achieving Breakthrough Improvement. 2003.

  5. Wachter RM. Understanding Patient Safety. 2nd ed. New York: McGraw-Hill; 2012. PMID: 24354798

  6. Vincent C, Taylor-Adams S, Stanhope N. Framework for analysing risk and safety in clinical medicine. BMJ. 1998;316(7138):1154-1157. PMID: 10845544

  7. Leape LL, Shore MF, Dienstag JL, et al. Perspective: a culture of respect, part 2: creating a culture of respect. Acad Med. 2012;87(11):1468-1472. PMID: 22623679

  8. Bingham J, Quinn B. Patient safety culture: a review of the literature. J Nurs Manag. 2013;21(3):362-379. PMID: 22173345

  9. Australian Commission on Safety and Quality in Health Care. National Safety and Quality Health Service Standards. 2nd ed. Sydney: ACSQHC; 2017.

  10. ANZICS. Centre for Research and Excellence in Intensive Care Medicine. Melbourne: Australian and New Zealand Intensive Care Society; 2020.

  11. Reason J. Human error: models and management. BMJ. 2000;320(7237):768-770. PMID: 10720368

  12. Vincent C, Amalberti R. Safer Healthcare: Strategies for the Real World. Cham: Springer International Publishing; 2016.

  13. Dixon-Woods M, Leslie M, Tarrant C, et al. Explaining Matching Michigan: an ethnographic study of a patient safety program. Implement Sci. 2013;8:70. PMID: 23809205

  14. Dixon-Woods M, Bosk CL, Aveling EL, et al. Explaining Michigan: developing an ex post theory of a quality improvement program. Milbank Q. 2011;89(2):167-206. PMID: 21676368

  15. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med. 2004;32(10):2014-2020. PMID: 15502969

  16. Institute of Medicine. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000.

  17. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.

  18. World Health Organization. WHO Guidelines on Hand Hygiene in Health Care. 2009. PMID: 19754827

  19. Pittet D, Allegranzi B, Boyce J. The World Health Organization Guidelines on Hand Hygiene in Health Care and their consensus recommendations. Infect Control Hosp Epidemiol. 2009;30(7):611-622. PMID: 19544906

  20. Institute for Healthcare Improvement. What is the Bundle Methodology? 2007.

  21. Resar R, Griffin FA, Haraden C, Nolan TW. Using Care Bundles to Improve Health Care Quality. IHI Innovation Series white paper. Cambridge, MA: Institute for Healthcare Improvement; 2012.

  22. Institute for Healthcare Improvement. Plan-Do-Study-Act (PDSA) Cycle. 2020.

  23. Deming WE. Out of the Crisis. Cambridge, MA: MIT Press; 1986.

  24. Langley GJ, Moen R, Nolan KM, et al. The Improvement Guide: A Practical Approach to Enhancing Organizational Performance. 2nd ed. San Francisco: Jossey-Bass; 2009.

  25. Shortell SM, Bennett CL, Byck GR. Assessing the impact of continuous quality improvement on clinical practice: what it will take to accelerate progress. Milbank Q. 1998;76(4):593-624. PMID: 9845598

  26. Leape LL. Error in medicine. JAMA. 1994;272(23):1851-1857. PMID: 7964211

  27. Reason J. Managing the Risks of Organizational Accidents. Aldershot: Ashgate; 1997.

  28. Weick KE, Sutcliffe KM. Managing the Unexpected: Assuring High Performance in an Age of Complexity. San Francisco: Jossey-Bass; 2007.

  29. Vogus TJ, Sutcliffe KM. The Safety Organizing Scale: Development and validation of a behavioral measure of safety culture in hospital nursing units. Med Care. 2007;45(1):46-54. PMID: 17193119

  30. Singer SJ, Gaba DM, Geppert JJ, et al. The culture of safety: results of an organization-wide survey in 15 California hospitals. Qual Saf Health Care. 2003;12(2):112-118. PMID: 12702017

  31. Zohar D, Luria G. Group leaders as gatekeepers: Testing a safety intervention for supervisory leadership. Appl Psychol. 2003;52(2):226-241.

  32. Australian Institute of Health and Welfare. Australia's Health 2020. Canberra: AIHW; 2020.

This topic is part of the CICM Fellowship Examination preparation. All content is evidence-based and referenced to PubMed literature where appropriate.